BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10091780)

  • 1. Outcome of palliative urinary diversion in the treatment of advanced malignancies.
    Shekarriz B; Shekarriz H; Upadhyay J; Banerjee M; Becker H; Pontes JE; Wood DP
    Cancer; 1999 Feb; 85(4):998-1003. PubMed ID: 10091780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
    Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
    J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome and management of ureteral obstruction secondary to gastric cancer.
    Migita K; Watanabe A; Samma S; Ohyama T; Ishikawa H; Kagebayashi Y
    World J Surg; 2011 May; 35(5):1035-41. PubMed ID: 21387134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction.
    Gasparini M; Carroll P; Stoller M
    Urology; 1991 Nov; 38(5):408-12. PubMed ID: 1719688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of palliative urinary diversion by percutaneous nephrostomy drainage and ureteral stenting among patients with advanced cervical cancer and obstructive uropathy: a prospective cohort.
    Lapitan MC; Buckley BS
    J Obstet Gynaecol Res; 2011 Aug; 37(8):1061-70. PubMed ID: 21481096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
    Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
    BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of ureterocystoneostomy for inner urinary diversion in locally advanced prostate carcinoma].
    Wawroschek F; Hamm M; Rathert P
    Urologe A; 1998 Jul; 37(4):372-6. PubMed ID: 9738288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer.
    Ekici S; Sahin A; Ozen H
    J Endourol; 2001 Oct; 15(8):827-9. PubMed ID: 11724123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial.
    Mokhmalji H; Braun PM; Martinez Portillo FJ; Siegsmund M; Alken P; Köhrmann KU
    J Urol; 2001 Apr; 165(4):1088-92. PubMed ID: 11257644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Affecting Survival Outcome After Percutaneous Nephrostomy as Palliative Urinary Diversion in Obstructive Uropathy due to Advance Cervical Cancer Patients.
    Noegroho BS; Kurniawan AP; Wijayanti Z; Mustafa A
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1211-1216. PubMed ID: 33906314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases.
    Heo JE; Jeon DY; Lee J; Ham WS; Choi YD; Jang WS
    Ann Surg Oncol; 2021 Apr; 28(4):2367-2373. PubMed ID: 33389298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintaining quality of life after palliative diversion for malignant ureteral obstruction.
    Markowitz DM; Wong KT; Laffey KJ; Bixon R; Nagler HM; Martin EC
    Urol Radiol; 1989; 11(3):129-32. PubMed ID: 2480679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous urinary diversion in patients with hormone-refractory prostate cancer.
    Dowling RA; Carrasco CH; Babaian RJ
    Urology; 1991 Feb; 37(2):89-91. PubMed ID: 1992595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course in patients with percutaneous nephrostomy for hydronephrosis associated with advanced cancer.
    Tanaka T; Yanase M; Takatsuka K
    Hinyokika Kiyo; 2004 Jul; 50(7):457-62. PubMed ID: 15334888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
    Kraemer PC; Borre M
    Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative urinary diversion in patients with advanced cervical cancer.
    Fukuoka M; Suzuki A; Fujii S; Okamura H
    Eur J Obstet Gynecol Reprod Biol; 1983 Dec; 16(4):293-8. PubMed ID: 6201402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Videoendoscopic cutaneous ureterostomy for palliative urinary diversion in advanced pelvic cancer.
    Puppo P; Ricciotti G; Bozzo W; Pezzica C; Geddo D; Perachino M
    Eur Urol; 1995; 28(4):328-33. PubMed ID: 8575502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative urinary diversion in patients with advanced pelvic malignancy.
    Meyer JE; Yatsuhashi M; Green TH
    Cancer; 1980 May; 45(10):2698-2701. PubMed ID: 6155198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of ureteral obstruction in primary cervical cancer.
    Lee SK; Jones HW
    Int J Gynaecol Obstet; 1994 Jan; 44(1):59-65. PubMed ID: 7907060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.